Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baker

Showing results (651-660 of 4,119) with videos related to

Pageof 412
Sort By:
The British Journal of Clinical Psychology|April 5, 2002
Self-reported and actual physiological responses in social phobiaRobert J Edelmann, Sarah R Baker
Nature: New Biology|March 3, 1971
Roles of parental and progeny DNA in 2 mechanisms of phage S13 recombinationR Baker, J Doniger, I Tessman
Journal of General Microbiology|January 1, 1978
Trypanosoma (Schizotrypanum) dionisii: effect of various agents on attachment and entry to macrophages in vitro and on morphogenesisJ R Baker, A J Liston
Cancer Research|October 1, 1980
Properties of uridine-cytidine kinase derived from L1210 leukemia cellsN K Ahmed, D R Baker
The Annals of Otology, Rhinology, and Laryngology|July 1, 1982
Extended transantral approach to pterygomaxillary tumorsC J Krause, S R Baker
The Biochemical Journal|April 15, 1980
The incorporation of radioactive fatty acids into the phospholipids of nerve-cell-body membranes in vivoR R Baker, H Y Chang
Journal of Medicinal Chemistry|May 1, 1982
Irreversible enzyme inhibitors. 202. Candidate active-site-directed irreversible inhibitors of 5-fluoro-2'-deoxyuridine phosphorylase from Walker 256 rat tumor derived from 1-benzyl-5-(3-ethoxybenzyl)uracilJ L Kelley, B R Baker
Otolaryngologic Clinics of North America|August 1, 1997
Conceptual considerations in head & neck reconstruction. Defect analysis and options for reconstructionR A Clevens, S R Baker
Journal of Medicinal Chemistry|November 1, 1970
Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluorideB R Baker, W T Ashton
Journal of Medicinal Chemistry|January 1, 1970
Irreversible enzyme inhibitors. CLXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 2,4-diamino-5(3,4-dichlorophenyl)pyrimidine with 6 substituents and some factors in their cell wall transportB R Baker, N M Vermeulen
Pageof 412

Showing results (651-660 of 4,119) with videos related to

Sort By:
Pageof 412
The British Journal of Clinical Psychology|April 5, 2002
Self-reported and actual physiological responses in social phobiaRobert J Edelmann, Sarah R Baker
Nature: New Biology|March 3, 1971
Roles of parental and progeny DNA in 2 mechanisms of phage S13 recombinationR Baker, J Doniger, I Tessman
Journal of General Microbiology|January 1, 1978
Trypanosoma (Schizotrypanum) dionisii: effect of various agents on attachment and entry to macrophages in vitro and on morphogenesisJ R Baker, A J Liston
Cancer Research|October 1, 1980
Properties of uridine-cytidine kinase derived from L1210 leukemia cellsN K Ahmed, D R Baker
The Annals of Otology, Rhinology, and Laryngology|July 1, 1982
Extended transantral approach to pterygomaxillary tumorsC J Krause, S R Baker
The Biochemical Journal|April 15, 1980
The incorporation of radioactive fatty acids into the phospholipids of nerve-cell-body membranes in vivoR R Baker, H Y Chang
Journal of Medicinal Chemistry|May 1, 1982
Irreversible enzyme inhibitors. 202. Candidate active-site-directed irreversible inhibitors of 5-fluoro-2'-deoxyuridine phosphorylase from Walker 256 rat tumor derived from 1-benzyl-5-(3-ethoxybenzyl)uracilJ L Kelley, B R Baker
Otolaryngologic Clinics of North America|August 1, 1997
Conceptual considerations in head & neck reconstruction. Defect analysis and options for reconstructionR A Clevens, S R Baker
Journal of Medicinal Chemistry|November 1, 1970
Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluorideB R Baker, W T Ashton
Journal of Medicinal Chemistry|January 1, 1970
Irreversible enzyme inhibitors. CLXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 2,4-diamino-5(3,4-dichlorophenyl)pyrimidine with 6 substituents and some factors in their cell wall transportB R Baker, N M Vermeulen
Pageof 412